Category Archives: Guest Blog

Is There Life After Big Pharma?

By Julian Upton | Published: March 11, 2010
Guest blog by Pharm Exec Europe’s Jacky Law. It’s hard to get precise figures of how many people have been taken off the payroll at pharma and biotech companies recently. According to staffing firm, Challender, Gray and Christmas, the combined industries shed 58,969 jobs in the first nine months of 2009, 15,000 more than the whole [...]
Also posted in Corporate Responsibility, Deals, Europe, Global | Tagged , , , , , | Leave a comment

Nothing is Rotten in the State of Denmark

By Julian Upton | Published: March 2, 2010
Guest blog by Reflector, Pharm Exec Europe’s Brussels correspondent. Denmark is still on the fringes of some European Union policies. Notably, it has not yet embraced the euro as a currency, and it keeps its distance from the common defence policy. But in one respect, its pharmaceutical industry has just shown that it is well abreast [...]
Also posted in Europe, Global, Regulatory | Tagged , , , , , , , | Leave a comment

US and Europe At Risk from Substandard Medicines

By Julian Upton | Published: February 25, 2010
Guest blog by Helen Disney, Chief Executive and Founder of the Stockholm Network, a pan-European think tank. When most of us look at taking a new medicine we tend to think it will make us better. Some of us may think about possible side effects but few of us expect the medicines we take to actually [...]
Also posted in Biotech, Emerging Markets, Europe, Global, Regulatory, Safety | Tagged , , , , , , , , , , , | Leave a comment

Help Us Help You

By Pharm Exec | Published: February 12, 2010
Sponsored Blog by: Craig Nestel Business Solutions Manager SAS Global Healthcare and Life Sciences Practice I wasn’t the biggest fan of the movie Jerry McGuire, but it certainly had its share of memorable quotes. Who can forget “mission statement” or “show me the money!” My personal favorite was “help me help you” which brings me to the subject of [...]
Also posted in Strategy | Tagged , , , , , , , | Leave a comment

A Few Words About Diversification

By Julian Upton | Published: February 1, 2010
Guest blog by Dr Brian White, an analyst at Shore Capital. As a result of the feared impact of the patent expiry cliff, the decimation of branded sales by multi-sourced generics and the obstacles erected, especially by managed care in the US, to slow the uptake of branded pharmaceuticals where a generic in the same class [...]
Also posted in Europe, Global, Strategy | Tagged , , , , , , | Leave a comment